Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance

Microbiology

Volumn 152, Issue 12, 2006, Pages 3701-3722

  Rognon, Bénédicte ^a   Kozovska, Zuzana ^b   Coste, Alix T ^a   Pardini, Giacomo ^a   Sanglard, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BENOMYL; BETA GALACTOSIDASE; CIS ACTING ELEMENT; HYDROGEN PEROXIDE; MADS DOMAIN PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PYRROLE DERIVATIVE; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CANDIDA ALBICANS; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGAL GENETICS; FUNGAL STRAIN; GENE CONTROL; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; START CODON; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIFUNGAL AGENTS; AZOLES; BENOMYL; BETA-GALACTOSIDASE; BINDING SITES; CANDIDA ALBICANS; CELL CYCLE PROTEINS; DNA, FUNGAL; DRUG RESISTANCE, MULTIPLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENES, MDR; HYDROGEN PEROXIDE; LUCIFERASES; MEMBRANE TRANSPORT PROTEINS; PROMOTER REGIONS (GENETICS);

CANDIDA; CANDIDA ALBICANS;

EID: 33846025066     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.29277-0     Document Type: Article

References (49)

1. Alarco, A. M. & Raymond, M. (1999). The bZip transcription factor-Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 181, 700-708.
2. Alarco, A. M., Balan, I., Talibi, D., Mainville, N. & Raymond, M. (1997). AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 272, 19304-19313.
3. Albertson, G. D., Niimi, M., Cannon, R. D. & Jenkinson, H. F. (1996). Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40, 2835-2841.
4. Ben-Yaacov, R., Knoller, S, Caldwell, G. A., Becker, J. M. & Koltin, Y. (1994). Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38, 648-652.
5. Broco, N., Tenreiro, S., Viegas, C. A. & Sa-Correia, I. (1999). FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator. Yeast 15, 1595-1608.
6. Chang, V. K., Fitch, M. J., Donato, J. J., Christensen, T. W., Merchant, A. M. & Tye, B. K. (2003). Mcm1 binds replication origins. J. Biol Chem 278, 6093-6100.
7. Coleman, D. C., Bennett, D. E., Sullivan, D. J., Gallagher, P. J., Henman, M. C., Shanley, D. B. & Russell, R. J. (1993). Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 19, 61-82.
8. Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J. & Sanglard, D. (2006). A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172, 2139-2156.
9. de Micheli, M., Bille, J., Schueller, C. & Sanglard, D. (2002). A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43, 1197-1214.
10. Fernandes, L., Rodrigues-Pousada, C. & Struhl, K. (1997). Yap, a novel family of eight bZIP proteins in Saccharomyces cerevisiae with distinct biological functions. Mol Cell Biol 17, 6982-6993.
11. Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A. & Koltin, Y. (1991). Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227, 318-329.
12. Fonzi, W. A. & Irwin, M. Y. (1993). Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728.
13. Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M. & Morschhauser, J. (1998). Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42, 3065-3072.
14. Ghannourn, M. A., Rex, J. H. & Galgiani, J. N. (1996). Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 34, 489-495.
15. Goldway, M., Teff, D., Schmidt, R., Oppenheim, A. B. & Koltin, Y. (1995). Multidrug resistance in Candida albicans: disruption of the BENr gene. Antimicrob Agents Chemother 39, 422-426.
16. Gupta, V., Kohli, A., Krishnamurthy, S., Puri, N., Aalamgeer, S. A., Panwar, S. & Prasad, R. (1998). Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 34, 192-199.
17. Hanahan, D. (1985). Techniques for transformation of E. coli. In DNA Cloning. a Practical Approach 1: Core Techniques, pp. 109-135. Edited by D. M. Glover. Oxford: IRL Press.
18. Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J. & White, T. C. (20O5). Drug-induced regulation of the MDR1 promoter in Candida albicans. Antimicrob Agents Chemother 49, 2785-2792.
19. Hiller, D., Stahl, S. & Morschhauser, J. (2006). Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Antimicrob Agents Chemother 50, 2300-2308.
20. Jelinsky, S. A. & Samson, L. D. (1999). Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci U S A 96, 1486-1491.
21. Karababa, M., Coste, A. T., Rognon, B., Bille, J. & Sanglard, D. (2004). Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48, 3064-3079.
22. Keleher, C. A., Goutte, C. & Johnson, A. D. (1988). The yeast cell-type-specific repressor alpha 2 acts cooperatively with a non-cell-type-specific protein. Cell 53, 927-936.
23. Kuge, S. & Jones, N. (1994). YAP1 dependent activation of TRX2 is essential for the response of Saccharomyces cerevisiae to oxidative stress by hydroperoxides. EMBO J 13, 655-664.
24. Law, D., Moore, C. B., Wardle, H. M., Ganguli, L. A., Keeney, M. G. & Denning, D. W. (1994). High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 34, 659-668.
25. Marr, K. A., Seidel, K., White, T. C. & Bowden, R. A. (2000). Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 181, 309-316.
26. Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B., Sullivan, D. J. & Coleman, D. C. (1998). Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 42, 1819-1830.
27. Nguyen, D. T., Alarco, A. M. & Raymond, M. (2001). Multiple Yap1p-binding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J Biol Chem 276, 1138-1145.
28. Passmore, S., Maine, G. T., Elble, R., Christ C. & Tye, B. K. (1988). Saccharomyces cerevisiae protein involved in plasmid maintenance is necessary for mating of MATα cells. J Mol Biol 204, 593-606.
29. Passmore, S., Elble, R. & Tye, B. K. (1989). A protein involved in minichromosome maintenance in yeast binds a transcriptional enhancer conserved in eukaryotes. Genes Dev 3, 921-935.
30. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39, 1-8.
31. Rottmann, M., Dieter, S., Brunner, H. & Rupp, S. (2003). A screen in Saccharomyces cerevisiae identified CaMCM1, an essential gene in Candida albicans crucial for morphogenesis. Mol Microbiol 47, 943-959.
32. Sa-Correia, I. & Tenreiro, S. (2002). The multidrug resistance transporters of the major facilitator superfamity, 6 years after disclosure of Saccharomyces cerevisiae genome sequence. J Biotechnol 98, 215-226.
33. Sanglard, D. & Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85.
34. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39, 2378-2386.
35. Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
36. Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A. & Bille, J. (1999). The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43, 2753-2765.
37. Spellman, P. T., Sherlock, G., Zhang, M. Q., Iyer, V. R., Anders, K., Eisen, M. B., Brown, P. O., Botstein, D. & Futcher, B. (1998). Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 9, 3273-3297.
38. Taglicht, D. & Michaelis, S. (1998). Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol 292, 130-162.
39. Tenreiro, S., Fernandes, A. R. & Sa-Correia, I. (2001). Transcriptional activation of FLR1 gene during Saccharomyces cerevisiae adaptation to growth with benomyl: role of Yap1p and Pdr3p. Biochem Biophys Res Commun 280, 216-222.
40. Toone, W. M. & Jones, N. (1999). AP-1 transcription factors in yeast. Curr Opin Genet Dev 9, 55-61.
41. Uhl, M. A. & Johnson, A. D. (2001). Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology 147, 1189-1195.
42. Wang, Y., Cao, Y. Y., Jia, X. M., Cao, Y. B., Gao, P. H., Fu, X. P., Ying, K., Chen, W. S. & Jiang, Y. Y. (2006). Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med 40, 1201-1209.
43. White, T. C. (1997). Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41, 1482-1487.
44. White, T. C., Pfaller, M. A., Rinaldi, M. G., Smith, J. & Redding, S. W. (1997). Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis 3, S102-S109.
45. White, T. C., Marr, K A. & Bowden, R. A. (1998). Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11, 382-402.
46. Wirsching, S., Michel, S., Kohler, G. & Morschhauser, J. (2000a). Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol 182, 400-404.
47. Wirsching, S., Michel, S. & Morschhauser, J. (2000b). Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36, 856-865.
48. Wynne, J. & Treisman, R. (1992). SRF and MCM1 have related but distinct DNA binding specificities. Nucleic Acids Res 20, 3297-3303.
49. Zhang, X., De Micheli, M., Coleman, S. T., Sanglard, D. & Moye-Rowley, W. S. (2000). Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p. Mol Microbiol 36, 618-629.